Literature DB >> 20552235

Motor neuron-immune interactions: the vicious circle of ALS.

Ana G Barbeito1, Pinar Mesci, Séverine Boillée.   

Abstract

Because microglial cells, the resident macrophages of the CNS, react to any lesion of the nervous system, they have for long been regarded as potential players in the pathogenesis of several neurodegenerative disorders including amyotrophic lateral sclerosis, the most common motor neuron disease in the adult. In recent years, this microglial reaction to motor neuron injury, in particular, and the innate immune response, in general, has been implicated in the progression of the disease, in mouse models of ALS. The mechanisms by which microglial cells influence motor neuron death in ALS are still largely unknown. Microglial activation increases over the course of the disease and is associated with an alteration in the production of toxic factors and also neurotrophic factors. Adding to the microglial/macrophage response to motor neuron degeneration, the adaptive immune system can likewise influence the disease process. Exploring these motor neuron-immune interactions could lead to a better understanding in the physiopathology of ALS to find new pathways to slow down motor neuron degeneration.

Entities:  

Mesh:

Year:  2010        PMID: 20552235      PMCID: PMC3511247          DOI: 10.1007/s00702-010-0429-0

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  218 in total

1.  Loss of the astrocyte glutamate transporter GLT1 modifies disease in SOD1(G93A) mice.

Authors:  Andrea C Pardo; Victor Wong; Leah M Benson; Margaret Dykes; Kohichi Tanaka; Jeffrey D Rothstein; Nicholas J Maragakis
Journal:  Exp Neurol       Date:  2006-06-06       Impact factor: 5.330

2.  Protective effects of an anti-inflammatory cytokine, interleukin-4, on motoneuron toxicity induced by activated microglia.

Authors:  Weihua Zhao; Wenjie Xie; Qin Xiao; David R Beers; Stanley H Appel
Journal:  J Neurochem       Date:  2006-10-02       Impact factor: 5.372

3.  The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice.

Authors:  Du-Chu Wu; Diane Bérangère Ré; Makiko Nagai; Harry Ischiropoulos; Serge Przedborski
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-28       Impact factor: 11.205

4.  Trial of celecoxib in amyotrophic lateral sclerosis.

Authors:  Merit E Cudkowicz; Jeremy M Shefner; David A Schoenfeld; Hui Zhang; Katrin I Andreasson; Jeffrey D Rothstein; Daniel B Drachman
Journal:  Ann Neurol       Date:  2006-07       Impact factor: 10.422

Review 5.  The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis.

Authors:  L Van Den Bosch; P Van Damme; E Bogaert; W Robberecht
Journal:  Biochim Biophys Acta       Date:  2006-05-17

Review 6.  ALS: a disease of motor neurons and their nonneuronal neighbors.

Authors:  Séverine Boillée; Christine Vande Velde; Don W Cleveland
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

7.  Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis.

Authors:  David R Beers; Jenny S Henkel; Qin Xiao; Weihua Zhao; Jinghong Wang; Albert A Yen; Laszlo Siklos; Scott R McKercher; Stanley H Appel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-16       Impact factor: 11.205

Review 8.  Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target.

Authors:  Siân C Barber; Richard J Mead; Pamela J Shaw
Journal:  Biochim Biophys Acta       Date:  2006-04-04

9.  Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1.

Authors:  Oleg Butovsky; Maya Koronyo-Hamaoui; Gilad Kunis; Eran Ophir; Gennady Landa; Hagit Cohen; Michal Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-24       Impact factor: 11.205

10.  Absence of tumor necrosis factor-alpha does not affect motor neuron disease caused by superoxide dismutase 1 mutations.

Authors:  Geneviève Gowing; Florence Dequen; Geneviève Soucy; Jean-Pierre Julien
Journal:  J Neurosci       Date:  2006-11-01       Impact factor: 6.167

View more
  21 in total

1.  C1q induction and global complement pathway activation do not contribute to ALS toxicity in mutant SOD1 mice.

Authors:  Christian S Lobsiger; Severine Boillée; Christine Pozniak; Amir M Khan; Melissa McAlonis-Downes; Joseph W Lewcock; Don W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-29       Impact factor: 11.205

2.  Immunological aspects in amyotrophic lateral sclerosis.

Authors:  Maria Carolina O Rodrigues; Júlio C Voltarelli; Paul R Sanberg; Cesario V Borlongan; Svitlana Garbuzova-Davis
Journal:  Transl Stroke Res       Date:  2012-05-03       Impact factor: 6.829

3.  NP001 regulation of macrophage activation markers in ALS: a phase I clinical and biomarker study.

Authors:  Robert G Miller; Rongzhen Zhang; Gilbert Block; Jonathan Katz; Richard Barohn; Edward Kasarskis; Dallas Forshew; Vidhya Gopalakrishnan; Michael S McGrath
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-09-05       Impact factor: 4.092

Review 4.  The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus.

Authors:  Michal Schwartz; Kuti Baruch
Journal:  EMBO J       Date:  2013-12-19       Impact factor: 11.598

5.  Early functional deficit and microglial disturbances in a mouse model of amyotrophic lateral sclerosis.

Authors:  Yannick Nicolas Gerber; Jean-Charles Sabourin; Miriam Rabano; Maria d M Vivanco; Florence Evelyne Perrin
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

Review 6.  The Role of immune and inflammatory mechanisms in ALS.

Authors:  P A McCombe; R D Henderson
Journal:  Curr Mol Med       Date:  2011-04       Impact factor: 2.222

7.  Excess circulating alternatively activated myeloid (M2) cells accelerate ALS progression while inhibiting experimental autoimmune encephalomyelitis.

Authors:  Ilan Vaknin; Gilad Kunis; Omer Miller; Oleg Butovsky; Shay Bukshpan; David R Beers; Jenny S Henkel; Eti Yoles; Stanley H Appel; Michal Schwartz
Journal:  PLoS One       Date:  2011-11-03       Impact factor: 3.240

8.  Exendin-4 ameliorates motor neuron degeneration in cellular and animal models of amyotrophic lateral sclerosis.

Authors:  Yazhou Li; Srinivasulu Chigurupati; Harold W Holloway; Mohamed Mughal; David Tweedie; Daniel A Bruestle; Mark P Mattson; Yun Wang; Brandon K Harvey; Balmiki Ray; Debomoy K Lahiri; Nigel H Greig
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

9.  The Role of the Innate Immune System in ALS.

Authors:  Sudarshan Phani; Diane Berengere Re; Serge Przedborski
Journal:  Front Pharmacol       Date:  2012-08-14       Impact factor: 5.810

10.  Complex Inflammation mRNA-Related Response in ALS Is Region Dependent.

Authors:  Sara Berjaoui; Mónica Povedano; Paula Garcia-Esparcia; Margarita Carmona; Ester Aso; Isidre Ferrer
Journal:  Neural Plast       Date:  2015-08-02       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.